|
1
|
Qian N, Ueno T, Kawaguchi-Sakita N,
Kawashima M, Yoshida N, Mikami Y, Wakasa T, Shintaku M, Tsuyuki S,
Inamoto T and Toi M: Prognostic significance of tumor/stromal
caveolin-1 expression in breast cancer patients. Cancer Sci.
102:1590–1596. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chiu WT, Lee HT, Huang FJ, Aldape KD, Tao
J, Steeg PS, Chou CY, Lu Z, Xie K and Huang S: Caveolin-1
upregulation mediates suppression of primary breast tumor growth
and brain metastases by stat3 inhibition. Cancer Res. 71:4932–4943.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sotgia F, Martinez-Outschoorn UE, Pavlides
S, Howell A, Pestell RG and Lisanti MP: Understanding the Warburg
effect and the prognostic value of stromal caveolin-1 as a marker
of a lethal tumor microenvironment. Breast Cancer Res. 13:213–225.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Witkiewicz AK, Dasgupta A, Nguyen KH, Liu
C, Kovatich AJ, Schwartz GF, Pestell RG, Sotiga F, Rui H and
Lisanti MP: Stromal caveolin-1 levels predict early DCIS
progression to invasive breast cancer. Cancer Biol Ther.
8:1071–1079. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Patani N, Martin LA, Reis-Filho JS and
Dowsett M: The role of caveolin-1 in human breast cancer. Brest
Cancer Res Treat. 131:1–15. 2013. View Article : Google Scholar
|
|
6
|
Sotgia F, Martinez-Outschoorn UE, Howell
A, Prestell RG, Pavlides S and Lisanti MP: Caveolin-1 and cancer
metabolism in the tumor microenvironment: Markers, models, and
mechanisms. Annu Rev Pathol. 7:423–467. 2012. View Article : Google Scholar
|
|
7
|
Du C, Chen L, Zhang HJ, Wang ZC, Liu WC,
Xie XD and Xie MJ: Caveolin-1 limits the contribution of BKCa
channel to MCF-7 breast cancer cell proliferation and invasion. Int
J Mol Sci. 15:20706–20722. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Paola C: Cancer associated fibroblasts:
The dark side of the coin. Am J Cancer Res. 1:482–497. 2011.
|
|
9
|
Buckley CD: Why does chronic inflammation
persist: An unexpected role for fibroblasts. Immunol Lett.
138:12–14. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Z, Wang N, Li W, Liu P, Chen Q, Situ
H, Zhong S, Guo L, Lin Y, Shen J and Chen J: Caveolin-1 mediates
chemoresistance in breast cancer stem cells via β-catenin/ABCG2
signaling pathway. Carcinogenesis. 35:2346–2356. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jen KY and Cheung VG: Identification of
novel p53 target genes in ionizing radiation response. Cancer Res.
65:7666–7673. 2005.PubMed/NCBI
|
|
12
|
Lee P, Vousden KH and Cheung EC: TIGAR,
TIGAR, burning bright. Cancer Metab. 2:12014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamaguchi H and Sakai R: Direct
interaction between carcinoma cells and cancer associated
fibroblasts for the regulation of cancer invasion. Cancers.
7:2054–2062. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Witkiewicz AK, Dasgupta A, Sammons S, Er
O, Potoczek MB, Guiles F, Sotgia F, Brody JR, Mitchell EP and
Lisanti MP: Loss of stromal caveolin-1 expression predicts poor
clinical outcome in triple negative and basal-like breast cancers.
Cancer Biol Ther. 10:135–43. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Witkiewicz AK, Dasgupta A, Sotgia F,
Mercier I, Pestell RG, Sabel M, Kleer CG, Brody JR and Lisanti MP:
An absence of stromal caveolin-1 expression predicts early tumor
recurrence and poor clinical outcome in human breast cancers. Am J
Pathol. 74:2023–2034. 2009. View Article : Google Scholar
|
|
16
|
EI-Gendi SM, Mostafa MF and EI-Gendi AM:
Stromal caveolin-1 expression in breast carcinoma. Correlation with
early tumor recurrence and clinical outcome. Pathol Oncol Res.
18:459–469. 2012. View Article : Google Scholar
|
|
17
|
Shan-Wei W, Kan-Lun X, Shu-Qin R, Li-Li Z
and Li-Rong C: Overexpression of caveolin-1 in cancer-associated
fibroblasts predicts good outcome in breast cancer. Breast Care
(Basel). 7:477–483. 2012. View Article : Google Scholar
|
|
18
|
Di Vizio D, Morello M, Sotgia F, Pestell
RG, Freeman MR and Lisanti MP: An absence of stromal caveolin-1 is
associated with advanced prostate cancer, metastatic disease and
epithelial Akt activation. Cell Cycle. 8:2420–2424. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Martinez-Outschoorn UE, Pavlides S,
Whitaker-Menezes D, Daumer KM, Milliman JN, Chiavarina B, Migneco
G, Wiktkiewicz AK, Martinez-Cantarin MP, Flomenberg N, et al: Tumor
cells induce the cancer associated fibroblast phenotype via
Caveolin-1 degradation: Implications for breast cancer and DCIS
therapy with autophagy inhibitors. Cell Cycle. 9:2423–2433. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pavlides S, Whitaker-Menezes D,
Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, Casimiro
MC, Wang C, Fortina P, Addya S, et al: The reverse Warburg effect:
Aerobic glycolysis in cancer associated fibroblasts and the tumor
stroma. Cell Cycle. 8:3984–4001. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kidd S, Spaeth E, Dembinski JL, Dietrich
M, Watson K, Klopp A, Battula VL, Weil M, Andreeff M and Marini FC:
Direct evidence of mesenchymal stem cell tropism for tumor and
wounding microenvironments using in vivo bioluminescent imaging.
Stem Cells. 27:2614–2623. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Crisan M, Yap S, Casteilla L, Chen CW,
Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, et al: A
perivascular origin for mesenchymal stem cells in multiple human
organs. Cell Stem Cell. 3:301–313. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jezierska-Drutel A, Rosenzweig SA and
Neumann CA: Role of oxidative stress and the microenvironment in
breast cancer development and progression. Adv Cancer Res.
119:107–125. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Engl T, Relja B, Marian D, Blumenberg C,
Müller I, Beecken WD, Jones J, Ringel EM, Bereiter-Hahn J, Jonas D
and Blaheta RA: CXCR4 chemokine receptor mediates prostate tumor
cell adhesion through alpha5 and beta3 integrins. Neoplasia.
8:290–301. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Peng SB, Peek V, Zhai Y, Paul DC, Lou Q,
Xia X, Eesalu T, Kohn W and Tang S: Akt activation, but not
extracellular bignal-reguhted kinase activation,is required for
SDF-lalpha/CXCR4-mediated migration of epitheloid carcinoma cells.
Mol Cancer Res. 3:227–236. 2005.PubMed/NCBI
|
|
26
|
Orimo A, Gupta PB, Sgroi DC,
Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL
and Weinberg RA: Stromal fibroblasts present in invasive human
breast carcinomas promote tumor growth and angiogenesis through
elevated SDF-1/CXCLl2 secretion. Cell. 121:335–348. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nagasawa T, Hirota S, Tachibana K,
Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H and
Kishimoto T: Defects of B-cell lymphopoiesis and bone-marrow
myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature.
382:635–638. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lewellis SW and Knaut H: Attractive
guidance: how the chemokine SDF1/CXCL12 guides different cells to
different locations. Semin Cell Dev Bio. 23:333–340. 2012.
View Article : Google Scholar
|
|
29
|
Balkwill F: The significance of cancer
cell expression of the chemokine receptor CXCR4. Semin Cancer Biol.
14:171–179. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Allinen M, Beroukhim R, Cai L, Brennan C,
Lahti-Domenici J, Juang H, Porter D, Hu M, Chin L, Richardson A, et
al: Molecular characterization of the tumor microenvironment in
breast cancer. Cancer Cell. 6:17–32. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li CF, Ma Y, Wei YZ and Xue Y:
Relationship between VEGF, EGF and invasion, metastasis of gastric
cancer cells. Chin J Cancer Res. 21:122–129. 2009. View Article : Google Scholar
|
|
32
|
Baek MK, Kim MH, Jang HJ, Park JS, Chung
IJ, Shin BA, Ahn BW and Jung YD: EGF stimulates uPAR expression and
cell invasiveness through ERK, AP-l, and NF-kappaB signaling in
human gastric carcinoma cells. Oncol Rep. 20:1569–1575.
2008.PubMed/NCBI
|
|
33
|
Hardwicke J, Schmaljohann D, Boyce D and
Thomas D: Epidermal growth factor therapy and wound healing-past,
present and future perspectives. Surgeon. 6:172–177. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Helfman DM, Kim EJ, Lukanidin E and
Grigorian M: The metastasis associated protein S100A4: role in
tumour progression and metastasis. Br J Cancer. 92:1955–1958. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tarabykina S, Griffiths TR, Tulchinsky E,
Mellon JK, Bronstein IB and Kriajevska M: Metastasis-associated
protein S100A4: spotlight on its role in cell migration. Curr
Cancer Drug Targets. 7:217–228. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Grum-Schwensen B, Klingelhofer J, Berg CH,
El-Naaman C, Grigorian M, Lukanidin E and Ambartsumian N:
Suppression of tumor development and metastasis formation in mice
lacking the S100A4(mts1) gene. Cancer Res. 65:3772–3780. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Green DR and Chipuk JE: p53 and
metabolism: Inside the TIGAR. Cell. 126:30–32. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bensaad K, Tsuruta A, Selak MA, Vidal MN,
Nakano K, Bartrons R, Gottlieb E and Vousden KH: TIGAR, a
p53-inducible regulator of glycolysis and apoptosis. Cell.
126:107–120. 2006. View Article : Google Scholar : PubMed/NCBI
|
